Nippon Express Europe Exhibits at LogiPharma 2023 for First Time

Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 is one of the world's largest international pharmaceutical trade shows, focusing on issues, trends and the latest technologies in pharmaceutical and...
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252

LogiPharma 2023 is one of the world's largest international pharmaceutical trade shows, focusing on issues, trends and the latest technologies in pharmaceutical and bio-pharmaceutical supply chains.

The exhibition attracted well over 1,400 participants involved in supply chains and logistics, including pharmaceutical and biotech companies, medical device manufacturers, and service and equipment providers as well as logistics providers.

The Nippon Express Group's meeting booth introduced the Group's global network of GDP*-certified business locations and its high-quality transport and storage services offering various temperature-control ranges tailored to pharmaceutical distribution processes.

The Nippon Express Group will continue expanding its global pharmaceutical logistics services and strengthening its global efforts in the pharmaceutical industry, which is positioned as a priority industry in the Group's business plan.

*GDP: Good Distribution Practice

Nippon Express website: https://www.nipponexpress.com/

Nippon Express Group's official LinkedIn account: https://www.linkedin.com/company/nippon-express-group/

Cision View original content:https://www.prnewswire.co.uk/news-releases/nippon-express-europe-exhibits-at-logipharma-2023-for-first-time-301851602.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;